<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To develop a risk-score model, based on available clinical data to assess absolute risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> among people with <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Data from the study to prevent non-<z:hpo ids='HP_0100651'>insulin dependent diabetes mellitus</z:hpo> (STOP-<z:mp ids='MP_0002057'>NIDDM</z:mp>) investigating <z:chebi fb="0" ids="2376">acarbose</z:chebi> treatment in individuals with IGT were used to develop multivariable Cox proportional hazards model for the time to <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The final model equation was externally validated using data from the Finnish <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">Cardiovascular Risk Factor</z:e> (FINRISK) population </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The risk-score model included the variables <z:chebi fb="0" ids="2376">acarbose</z:chebi> treatment, gender, serum <z:chebi fb="0" ids="17855">triglyceride</z:chebi> level, waist circumference, fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, height, history of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) and <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The final model yielded an area under the receiver-operating-characteristic curve (AUC(ROC)) of 0.64 when applied to people with IGT in the STOP-<z:mp ids='MP_0002057'>NIDDM</z:mp>, and 0.84 and 0.90 when applied to FINRISK population with IGT alone and IGT and <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance combined, respectively; AUC(ROC) is a measure of the discriminatory power of the model (1, perfect discrimination) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: The STOP-<z:mp ids='MP_0002057'>NIDDM</z:mp> risk-score is a simple and validated tool that can identify high-risk individuals with IGT who would benefit most from type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> prevention strategies, such as lifestyle management or early <z:chebi fb="0" ids="2376">acarbose</z:chebi> treatment </plain></SENT>
</text></document>